The reductions in cortical ZnT3 gene expression, by 45-60%, were already well-established at Braak stage 4, when neocortical regions are still relatively unaffected by AD-related neurofibrillary tangle pathology and overt neuronal loss [32]. The gene discussed is SLC30A3; the disease is Alzheimer disease.